28 years designing and implementing sustainable solutions to patient access challenges.
Discover the people and purpose behind our work to expand access.
Explore the patient-centered approach and evidence behind our work.
Join our team and help shape the future of access.
A network of experienced access specialists around the world.
Real-world insights and best practices to inform more sustainable access to healthcare strategies.
View All
Learnings from access programs and initiatives around the world.
Peer-reviewed research advancing healthcare access.
Perspectives, ideas, and news shaping the future of healthcare access.
Building sustainable access to healthcare solutions for every step of the patient journey.
Learn More
Overcoming complex self-pay market barriers with sustainable access strategies.
Personalized support to help patients complete their course of treatment.
Helping patients get the right diagnosis sooner.
Making care and treatment more convenient for patients.
Removing treatment affordability barriers so patients can access the treatment they need.
Technology that connects, simplifies, and continuously improves the patient journey.
Real-world data for better patient access
Explore peer-reviewed publications on Axios-managed access programs and tools, contributing real-world evidence and insights to the evolving body of knowledge on healthcare access.
Publication
Journal of Clinical Oncology
Filter
This study analyzed data from over 18,000 cancer patients across 20 countries to see which patient and program factors best predict who survives and who stays on their prescribed treatment schedule. Country, medication type, and age were strongly linked to survival, while country, medication, and wh
This study tracked over 600 cancer patients in a Lebanese drug access program to see how the country's economic collapse, which began in 2019, affected their chances of survival, even though the program itself kept covering their medication costs throughout the crisis. Patients who started treatment
This study followed over 100 UAE patients with chronic diseases for a full year to identify what predicts whether someone stays on their prescribed treatment or drops out of care. Patients who felt satisfied with the time spent with their doctor and who had lower stress and anxiety were far more lik
This study followed 460 lymphoma patients across seven countries enrolled in a subsidized cancer drug program to see what factors influenced whether they survived and stayed on treatment. Patients who received regular phone check-ins had notably better survival, and doctors who treated more patients
This study looked at over 100 patients in the UAE managing chronic conditions like heart failure, multiple sclerosis, and psoriasis to understand what helps someone successfully manage their disease day-to-day. Patients who understood their disease well, felt involved in treatment decisions, and had
This study followed over 1,300 COPD patients in Egypt to understand what drives patients to stop their prescribed inhaler treatment, focusing on the roles of pharmacists and family support. Patients with a spouse, children, or siblings helping them manage treatment were more likely to stay on their
This study analyzed financial data from over 1,400 patients in Thailand, UAE, and Mexico to see how well Axios’ Patient Financial Evaluation Tool (PFET), a tool that combines income, assets, and standard of living, captures a person's true ability to pay for medication. The analysis found seven dist
This study surveyed patients and physicians across ten developing countries to understand what shapes how much patients are willing to pay for treatments for chronic heart failure and psoriasis. Income was the single biggest factor for both diseases, while for psoriasis, education level and out-of-p
This study interviewed nearly 1,000 patients exiting pharmacies in Ghana, Kenya, Nigeria, Tanzania, and Uganda to understand how people seek malaria treatment and whether they get properly diagnosed and prescribed effective medicine. Patients frequently purchased recommended malaria treatment even w